These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36497459)

  • 1. Investigational Microbiological Therapy for Glioma.
    Wang J; Liu Y; Zhang A; Yu W; Lei Q; Xiao B; Luo Z
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
    López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
    Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A narrative review of research progress on drug therapies for glioblastoma multiforme.
    Zheng X; Tang Q; Ren L; Liu J; Li W; Fu W; Wang J; Du G
    Ann Transl Med; 2021 Jun; 9(11):943. PubMed ID: 34350258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
    López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
    Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
    Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
    BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide.
    Ding Y; Zhang C; He L; Song X; Zheng C; Pan Y; Yu S
    Bioengineered; 2021 Dec; 12(2):10791-10798. PubMed ID: 34753395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.
    Wang J; Zuo J; Wahafu A; Wang MD; Li RC; Xie WF
    CNS Neurosci Ther; 2020 Mar; 26(3):297-308. PubMed ID: 31318172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).
    Zeng Z; Chen Y; Geng X; Zhang Y; Wen X; Yan Q; Wang T; Ling C; Xu Y; Duan J; Zheng K; Sun Z
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35506469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems.
    Cao H; Li X; Wang F; Zhang Y; Xiong Y; Yang Q
    Curr Med Chem; 2020; 27(4):599-629. PubMed ID: 31400262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent.
    Uram Ł; Markowicz J; Misiorek M; Filipowicz-Rachwał A; Wołowiec S; Wałajtys-Rode E
    Eur J Pharm Sci; 2020 Sep; 152():105439. PubMed ID: 32615261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells.
    Filippi-Chiela EC; Thomé MP; Bueno e Silva MM; Pelegrini AL; Ledur PF; Garicochea B; Zamin LL; Lenz G
    BMC Cancer; 2013 Mar; 13():147. PubMed ID: 23522185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.
    Wang H; Ren S; Xu Y; Miao W; Huang X; Qu Z; Li J; Liu X; Kong P
    Anticancer Drugs; 2019 Jan; 30(1):81-88. PubMed ID: 30273182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
    Tomar VS; Patil V; Somasundaram K
    Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends in targeted therapies for glioblastoma multiforme.
    Ohka F; Natsume A; Wakabayashi T
    Neurol Res Int; 2012; 2012():878425. PubMed ID: 22530127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
    Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
    Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating malignant glioma in Chinese patients: update on temozolomide.
    Chang L; Su J; Jia X; Ren H
    Onco Targets Ther; 2014; 7():235-44. PubMed ID: 24600235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.